GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aytu Biopharma AYTU · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.79

-2.19%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Aytu Biopharma

Our reporting

We have not reported on Aytu Biopharma yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.10 a share.

Past results

Reported against what analysts expected

22 Sept 202613 May 20263 Feb 202613 Nov 202523 Sept 202512 Feb 2025
Earnings per share-0.05-0.53-1.05-0.08-2.92-0.28
Forecast-0.29-0.31-0.26-0.06-0.02-0.28
Revenue$16.1m$12.4m$15.2m$13.9m$15.1m$16.2m
Forecast$12.3m$12.1m$12.2m$12.6m$17.9m$15.6m

Key events

  1. 6 Jan 202320-to-1 reverse split
  2. 9 Dec 202010-to-1 reverse split
  3. 13 Aug 201820-to-1 reverse split
  4. 20 Oct 2017Listed
  5. 29 Aug 201720-to-1 reverse split
  6. 1 Jul 201612-to-1 reverse split

Aytu Biopharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.